111 Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

111 şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-0.06%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-0.06%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Recent updates

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

Aug 18

Is 111 (NASDAQ:YI) A Risky Investment?

Apr 09

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

Mar 05

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

Jan 29

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Dec 25

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Dec 04

111 reports Q3 results, provides Q4 revenue guidance

Nov 19

111, Inc.: Cheap But Risky And Controlled By Founders

Nov 16

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: YI şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: YI şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

111 Piyasaya Karşı Temettü Getirisi

YI temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (YI)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Consumer Retailing)	1.1%
Analist tahmini (YI) (3 yıla kadar)	0%

Önemli Temettü: YI şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, YI şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: YI şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: YI herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

111 Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Recent updates

111, Inc. Announces Board Changes

111, Inc. to Report Q3, 2024 Results on Nov 28, 2024

111, Inc. Announces Receipt of Notification from Nasdaq

111, Inc. Announces Receipt of Notification from Nasdaq

A Look At The Intrinsic Value Of 111, Inc. (NASDAQ:YI)

111, Inc. to Report Q2, 2024 Results on Aug 29, 2024

111, Inc. announced delayed 20-F filing

111, Inc. to Report Q4, 2023 Results on Mar 21, 2024

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

Gang Yu, Junling Liu and Shanghai Guosheng Capital Management Co., Ltd. cancelled the unsolicited preliminary non-binding proposal letter to acquire 111, Inc. (NasdaqGM:YI) from Gang Yu, Junling Liu and others.

New minor risk - Share price stability

Third quarter 2023 earnings released

111, Inc. to Report Q3, 2023 Results on Nov 30, 2023

Second quarter 2023 earnings released: CN¥0.68 loss per share (vs CN¥1.14 loss in 2Q 2022)

111, Inc. to Report Q2, 2023 Results on Aug 24, 2023

First quarter 2023 earnings released: CN¥0.38 loss per share (vs CN¥1.33 loss in 1Q 2022)

111, Inc. to Report Q1, 2023 Results on Jun 15, 2023

Full year 2022 earnings released: CN¥5.00 loss per share (vs CN¥8.08 loss in FY 2021)

Third quarter 2022 earnings released: CN¥1.16 loss per share (vs CN¥3.05 loss in 3Q 2021)

Insufficient new directors

111, Inc. to Report Q3, 2022 Results on Dec 01, 2022

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Second quarter 2022 earnings released

111, Inc. Provides Revenue Guidance

111 Non-GAAP EPS of -$0.14, revenue of $453.4M

111, Inc. to Report Q2, 2022 Results on Aug 25, 2022

111, Inc.'s Inexorable Drive Towards Profitability

First quarter 2022 earnings released

Insufficient new directors

111, Inc. to Report Q1, 2022 Results on Jun 16, 2022

Full year 2021 earnings: Revenues in line with analyst expectations

111, Inc. to Report Q4, 2021 Results on Mar 17, 2022

Third quarter 2021 earnings released

Solid Earnings, Modest Buyback Fail To Boost Drug Seller 111, Inc.

111, Inc. (NasdaqGM:YI) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2021 earnings released

111, Inc. Provides Preliminary Revenue Guidance for the Third Quarter of 2021

Health Check: How Prudently Does 111 (NASDAQ:YI) Use Debt?

111, Inc.: Undervalued After Recent Unjustified Share Price Collapse; 50% Upside

First quarter 2021 earnings released: CN¥1.77 loss per share (vs CN¥1.52 loss in 1Q 2020)

111, Inc. Provides Revenue Guidance for the Second Quarter of 2021

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

Is 111 (NASDAQ:YI) A Risky Investment?

Full year 2020 earnings released: CN¥5.54 loss per share (vs CN¥6.11 loss in FY 2019)

111, Inc. Provides Earnings Guidance for the First Quarter of 2021

Could The 111, Inc. (NASDAQ:YI) Ownership Structure Tell Us Something Useful?

111, Inc. to Report Q4, 2020 Results on Mar 18, 2021

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

New 90-day high: US$12.70

Did You Miss 111's (NASDAQ:YI) 70% Share Price Gain?

New 90-day high: US$7.62

111 (NASDAQ:YI) Has Debt But No Earnings; Should You Worry?

Why 111, Inc. (NASDAQ:YI) Could Be Worth Watching

Third quarter 2020 earnings released: CN¥1.32 loss per share

111 reports Q3 results, provides Q4 revenue guidance

111, Inc.: Cheap But Risky And Controlled By Founders

New 90-day high: US$7.45

111, Inc. Announces Management Changes

111, Inc. and Shanghai Uniondrug Information Technology Join Hands to Advance Innovation in Commercial Insurance Payment

New 90-day low - US$5.96

First half earnings released

111, Inc. to Report Q2, 2020 Results on Aug 20, 2020

New 90-day low - US$6.14

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin